Detecting pancreatic cancer effectively relies on several critical diagnostic tools. Key among them is the pancreatic biopsy, a definitive test for identifying cancerous cells. Imaging tests like CT scans and MRI of the abdomen provide detailed images of the pancreas, essential for pinpointing tumors. The endoscopic ultrasound and endoscopic retrograde cholangiopancreatography (ERCP) are instrumental in […]
Pancreatic cancer, medically termed “Pancreatic Carcinoma,” is a serious condition originating in the pancreas, an essential organ located behind the stomach. The pancreas plays a crucial role in digestion by producing enzymes that help in the absorption of fats and other nutrients. It also regulates blood glucose levels through hormones like insulin and glucagon, produced […]
Marine organisms offer a vast reservoir of cytotoxic compounds with potential therapeutic applications in treating various cancers. These biomedicines, known as marine drugs, are derived from a variety of marine species and have shown promise in pharmacological studies due to their unique chemical properties and modes of action. Marine Drugs and Their Sources Several marine […]
Nicotine, a potent chemical found in tobacco leaves, is the primary reason people become addicted to smoking cigarettes and cigars. This substance stimulates the nervous system, providing a temporary sensation of relief or pleasure, which leads to habitual use despite its significant health risks. The Destructive Impact of Nicotine and Tobacco Smoke The consequences of […]
A study has highlighted a significant health concern for men who consume high doses of vitamin B supplements, particularly vitamins B6 and B12. According to research reported by the Daily Mail and conducted by American scientists, these supplements, often marketed for their energy-boosting properties, may substantially increase the risk of lung cancer, especially among smokers. […]
In a groundbreaking development for cancer treatment in India, Zydus Lifesciences has launched Olaparib under the brand name IBYRA, a pioneering PARP inhibitor designed to target specific genetic mutations. This strategic move aims to provide a more personalized and effective approach to combating various types of cancers, including breast, ovarian, prostate, and pancreatic cancers, which […]
Kinnate Biopharma Inc. (Nasdaq: KNTE), a leading clinical-stage precision oncology company, has announced a definitive merger agreement with XOMA Corporation, setting the stage for a transformative leap in the field of cancer research and treatment. The merger, valued at a cash price per share of Kinnate common stock ranging between $2.3352 and $2.5879, comprises a […]
In a sobering announcement from Buckingham Palace on Monday, it was revealed that King Charles III has been diagnosed with an unspecified type of cancer, leading to a temporary postponement of his public-facing duties. The palace statement highlighted the king’s positive outlook and his intention to return to full public duty as swiftly as possible. […]
Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) have announced a significant amendment to their collaboration agreement, accompanied by a substantial $320 million equity investment by Gilead in Arcus common stock at $21.00 per share. This strategic investment and collaboration amendment are set to accelerate the growth of their joint development programs […]
Bristol Myers Squibb (NYSE: BMY) has announced results from its Phase 3 CheckMate -67T trial, which could revolutionize treatment for patients with advanced or metastatic clear cell renal cell carcinoma (ccRCC). The trial evaluated the subcutaneous formulation of PD-1 immune checkpoint inhibitor Opdivo (nivolumab), co-formulated with Halozyme’s proprietary recombinant human hyaluronidase (rHuPH20), referred to as […]